title: Benefits, risks of SGLT2 inhibitors explored at session.
authors.forename: Mary K
authors.initials: MK
authors.lastname: Caffrey
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D015431:Weight Loss
chemical_list: D007004:Hypoglycemic Agents; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D005947:Glucose